HOME >> MEDICINE >> NEWS
GlaxoSmithKline Drug Discovery and Development Research Grant Program 2003

Research Triangle Park, NC (April 10, 2003) - GlaxoSmithKline (GSK) will award $500,000 in grants for innovative HIV/AIDS drug research in recognition of the need to produce new alternatives and hope in the fight against the HIV/AIDS pandemic.

Applications are now being solicited for 2003 research grants and must be submitted by July 31. The one-time research grants range from $25,000 to $150,000 and are intended to further the development of inventive treatments for HIV/AIDS, including:

  • therapies aimed at treating infection,
  • prophylactic vaccines, or
  • microbicides designed to prevent transmission of the virus.

For detailed information about the GSK Drug Discovery and Development Research Grant Program, as well as an application, please call 1-888-527-6935 or visit www.dddresearchgrant.com.

"It has been gratifying to fund such innovative research and to recognize researchers - here and internationally - of this caliber," said Doug Manion, M.D., vice president of clinical development for GSK. "We've been very pleased with the diversity of the projects submitted, which have ranged from research on protein recognition to the molecular virology of HIV integration, and believe the grants provide us with a way to demonstrate our commitment to scientific research investigating the mysteries of HIV and AIDS."

Since the inception of the Drug Discovery and Development Research Grant Program in 2001, GSK has honored nine researchers for their groundbreaking work toward new pharmaceutical strategies to combat the HIV virus.

The research grant carries no obligation to the recipient's organization for licensure, patenting or transfer of confidential information, although GSK may discuss the possibility of future collaboration with some applicants.

An Expert Review Board composed of acknowledged leaders in the field of HIV/AIDS will independently judge and c
'"/>

Contact: Elaine Salewske
esalewske@pcipr.com
312-558-1770
Public Communications Inc.
10-Apr-2003


Page: 1 2

Related medicine news :

1. TB Alliance announces new drug discovery program with GlaxoSmithKline
2. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
3. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
4. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2003
5. GlaxoSmithKline Drug Discovery and Development Award 2002
6. GlaxoSmithKline Drug Discovery and Development Award 2002
7. Discovery of pathway in learning impairment caused by liver disease may lead to drug treatment
8. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
9. Discovery of the oldest remains of a woman who died in childbirth
10. Discovery sheds light on how cancer cells grow and divide
11. Discovery changes ideas about damage from strokes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
Cached News: